FDA identifies deadly heparin contaminant

updated 11:44 a.m. ET March 19, 2008

WASHINGTON - U.S. health regulators have identified the contaminant found in Baxter International's blood thinner heparin, which may be to blame for 19 deaths.

The Food and Drug Administration says a chemical compound called oversulfated chondroitin sulfate has been found in samples of the drug tied to death and allergic reactions.

FDA staff say the chemical comes from a family similar to heparin, but that it is not approved in the U.S. or abroad as a medical treatment.

FDA drug center director Janet Woodcocks says the agency can't rule whether it was deliberately introduced into the product, but is 99 percent sure it's not a natural component.

Baxter is based in Deerfield, Ill.

MORE FROM HEALTH CARE

Health care Section Front

Fentanyl deaths topped 1,000 over two years N.J. licenses to require organ donation decision Health officials back paperless prescriptions Singapore may pay donors for kidneys Pills to pillows: When to toss them Family sues for muscular dystrophy drug Surgeons taking kidneys through the navel ‘Cuckoo’s Nest’ hospital to be torn down Health insurance caps leave patients stranded Hospital bullies take a toll on patient safety Health care Section Front   Add Health care headlines to your news reader: